首页 > 最新文献

BMC Ophthalmology最新文献

英文 中文
Effect of the iris-ciliary angle on the prediction of the vault for phakic implantable collamer lens in the manufacturer's calculator. 虹膜-睫状体角对制造商计算器中的角膜穹窿预测的影响。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-11-11 DOI: 10.1186/s12886-024-03756-4
Yingjie Ni, Siyuan He, Huihui Jin, Yuanpeng Wu, Yangqi Zhao, Chaoyang Hong, Peijin Qiu, Ting Shen

Background: This study aims to explore the effects of the iris-ciliary angle (ICA) on the accurate prediction of the vault after implantable collamer lens (ICL) using the manufacturer's online calculation and ordering system (OCOS).

Methods: The participants were categorized into three groups according to the size of ICA as follows: narrow ICA group (< 40°); normal ICA group (40°-60°); wide ICA group (> 60°). We compared the preoperative ocular characteristics and postoperative vault at 3 months among the three groups. Bivariate correlation was used to analyze the correlation between vault and ICA, and multiple linear regression was used to further analyze the correlation between vault and preoperative parameters. Ordered multicategorical logistic regression analyses were used to further illustrate the effect of different ICA groups on postoperative vault distribution.

Results: This study included 278 eyes of 157 individuals. There were no statistically significant differences in preoperative ocular parameters among the three ICA groups, while the postoperative vault was minimal in the wide ICA group, followed by the normal and then the narrow ICA group (p < 0.001). The correlation between ICA and vault at 3 months postoperatively was significant in both bivariate correlation and multiple linear regression analysis (both P < 0.001). Ordered multicategorical logistic regression analyses showed that the odds of having a higher vault were 2.586 (P = 0.002) and 5.534 (P < 0.001) times in the normal and narrow ICA groups, respectively, compared to the wide ICA group.

Conclusions: The size of the ICA has a significant impact on vault created by the recommended ICL size for OCOS. Therefore, ICA should be considered when selecting ICL size using the OCOS recommended sizes preoperatively.

背景:本研究旨在探讨虹膜睫状角(ICA)对使用制造商的在线计算和订购系统(OCOS)准确预测植入式角膜塑形镜(ICL)术后穹窿的影响:方法:根据ICA的大小将参与者分为以下三组:狭ICA组(60°);窄ICA组(60°);高ICA组(60°)。我们比较了三组患者术前的眼部特征和术后 3 个月的穹隆。采用二元相关分析穹窿与 ICA 的相关性,并采用多元线性回归进一步分析穹窿与术前参数的相关性。有序多分类逻辑回归分析用于进一步说明不同 ICA 组别对术后穹窿分布的影响:本研究共纳入 157 人的 278 只眼睛。三个 ICA 组的术前眼部参数差异无统计学意义,而宽 ICA 组的术后穹窿最小,其次是正常 ICA 组,然后是窄 ICA 组(P 结论:宽 ICA 组的术后穹窿最小,其次是正常 ICA 组,然后是窄 ICA 组):ICA 的大小对 OCOS 推荐 ICL 大小所产生的穹窿有很大影响。因此,在术前使用 OCOS 推荐尺寸选择 ICL 尺寸时,应考虑到 ICA。
{"title":"Effect of the iris-ciliary angle on the prediction of the vault for phakic implantable collamer lens in the manufacturer's calculator.","authors":"Yingjie Ni, Siyuan He, Huihui Jin, Yuanpeng Wu, Yangqi Zhao, Chaoyang Hong, Peijin Qiu, Ting Shen","doi":"10.1186/s12886-024-03756-4","DOIUrl":"10.1186/s12886-024-03756-4","url":null,"abstract":"<p><strong>Background: </strong>This study aims to explore the effects of the iris-ciliary angle (ICA) on the accurate prediction of the vault after implantable collamer lens (ICL) using the manufacturer's online calculation and ordering system (OCOS).</p><p><strong>Methods: </strong>The participants were categorized into three groups according to the size of ICA as follows: narrow ICA group (< 40°); normal ICA group (40°-60°); wide ICA group (> 60°). We compared the preoperative ocular characteristics and postoperative vault at 3 months among the three groups. Bivariate correlation was used to analyze the correlation between vault and ICA, and multiple linear regression was used to further analyze the correlation between vault and preoperative parameters. Ordered multicategorical logistic regression analyses were used to further illustrate the effect of different ICA groups on postoperative vault distribution.</p><p><strong>Results: </strong>This study included 278 eyes of 157 individuals. There were no statistically significant differences in preoperative ocular parameters among the three ICA groups, while the postoperative vault was minimal in the wide ICA group, followed by the normal and then the narrow ICA group (p < 0.001). The correlation between ICA and vault at 3 months postoperatively was significant in both bivariate correlation and multiple linear regression analysis (both P < 0.001). Ordered multicategorical logistic regression analyses showed that the odds of having a higher vault were 2.586 (P = 0.002) and 5.534 (P < 0.001) times in the normal and narrow ICA groups, respectively, compared to the wide ICA group.</p><p><strong>Conclusions: </strong>The size of the ICA has a significant impact on vault created by the recommended ICL size for OCOS. Therefore, ICA should be considered when selecting ICL size using the OCOS recommended sizes preoperatively.</p>","PeriodicalId":9058,"journal":{"name":"BMC Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glaucoma medication non-adherence rate and associated barriers among glaucoma patients in Hawassa, Ethiopia. 埃塞俄比亚哈瓦萨青光眼患者不坚持用药率及相关障碍。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-11-08 DOI: 10.1186/s12886-024-03750-w
Balcha Negese Kebede, Seid Mohammed Seid, Biruktayit Kefyalew, Eyerus Gesese

Background: The estimated number peoples aged 40 to 80 years affected with glaucoma were 76.0 million in 2020 and 111.8 in 2040 globally. The estimated number peoples aged 40 to 80 years affected with glaucoma were 76.0 million in 2020 and 111.8 in 2040. This study identified glaucoma medication non-adherence rates and associated barriers among patients with glaucoma attending Hawassa University Comprehensive Specialized Hospital.

Methods: A prospective cross-sectional study was conducted on 340 patients diagnosed with glaucoma who were administered ocular hypotensive medication at least for one week before current visit and those who were diagnosed and prescribed the medication, currently presented to the hospital as new attendant. A systematic random sampling technique was used to select study participants. Data was collected using a validated questionnaire by interviewing patients and reviewing their medical charts from May 01 to November 30, 2022. The collected data checked for completeness, entered to SPSS 22. Descriptive and binary logistic regression analysis were done using the software. The findings were presented using tables and Pie-charts. A p-value ≤ 0.05 was used to indicate statistical significance.

Results: About 340 patients participated in this study with response rate of 90%. More than half of them (59.4%) were male. Mean age of the study participants was 60.2 ± 3.17SD years. The majority came from rural areas (186 (54.71%). Approximately 62.4% of them were with bilateral glaucoma while 47.10% were at advanced stage at least in one eye. The glaucoma non-adherence rate was 54.71% (95% CI; 50.90-58.50). Forgetfulness (AOR 28.32 (95% CI;14.80-54.16), difficulty with schedule AOR 2.52 (95% CI;1.009-6.29), believing eye drops were not effective AOR 6.35 (95% CI;1.17-34.49) and poor self-efficacy AOR 10.96 (95% CI;1.26-95.57) were barriers significantly associated with non-adherence.

Conclusion and recommendation: The nonadherence rate to glaucoma medication among patients with glaucoma attending Hawassa University comprehensive hospital was high (54.71%). Forgetfulness, difficulty with schedule, belief that the drug was not effective and poor self-efficacy were barriers associated with glaucoma medication non-adherence. Health workers better to properly council and inform the patients about the disease nature, goal of treatment, danger of nonadherence to administered medication and mechanism to increase their adherence such as setting reminder.

背景:据估计,2020 年全球 40 至 80 岁青光眼患者人数为 7 600 万人,2040 年为 1 111.8 人。据估计,2020 年全球 40 至 80 岁青光眼患者人数为 7600 万,2040 年为 11180 万。本研究确定了哈瓦萨大学综合专科医院青光眼患者的青光眼用药不依从率及相关障碍:对 340 名确诊为青光眼的患者进行了前瞻性横断面研究,这些患者在本次就诊前至少一周服用了降眼压药物,并且确诊为青光眼并开具了降眼压药物处方,但目前作为新就诊者到医院就诊。研究采用系统随机抽样技术挑选参与者。在 2022 年 5 月 1 日至 11 月 30 日期间,通过采访患者和查看病历,使用有效问卷收集数据。收集的数据经过完整性检查后,输入 SPSS 22。使用该软件进行了描述性分析和二元逻辑回归分析。分析结果以表格和饼图的形式呈现。P值≤0.05表示统计学意义:约有 340 名患者参与了这项研究,回复率为 90%。其中一半以上(59.4%)为男性。研究参与者的平均年龄为 60.2 ± 3.17SD 岁。大多数来自农村地区(186 人,占 54.71%)。其中约 62.4% 的人患有双侧青光眼,47.10% 的人至少有一只眼睛处于晚期。青光眼不依从率为 54.71% (95% CI; 50.90-58.50)。遗忘(AOR 28.32 (95% CI; 14.80-54.16))、难以安排时间 AOR 2.52 (95% CI; 1.009-6.29)、认为眼药水无效 AOR 6.35 (95% CI; 1.17-34.49)和自我效能感差 AOR 10.96 (95% CI; 1.26-95.57)是与不坚持治疗显著相关的障碍:哈瓦萨大学综合医院的青光眼患者不坚持用药的比例很高(54.71%)。健忘、难以按时服药、认为药物无效和自我效能低是青光眼患者不坚持服药的障碍。医护人员最好能适当地向患者解释并告知疾病的性质、治疗目标、不坚持服药的危害以及提高患者坚持服药的机制,如设置提醒。
{"title":"Glaucoma medication non-adherence rate and associated barriers among glaucoma patients in Hawassa, Ethiopia.","authors":"Balcha Negese Kebede, Seid Mohammed Seid, Biruktayit Kefyalew, Eyerus Gesese","doi":"10.1186/s12886-024-03750-w","DOIUrl":"10.1186/s12886-024-03750-w","url":null,"abstract":"<p><strong>Background: </strong>The estimated number peoples aged 40 to 80 years affected with glaucoma were 76.0 million in 2020 and 111.8 in 2040 globally. The estimated number peoples aged 40 to 80 years affected with glaucoma were 76.0 million in 2020 and 111.8 in 2040. This study identified glaucoma medication non-adherence rates and associated barriers among patients with glaucoma attending Hawassa University Comprehensive Specialized Hospital.</p><p><strong>Methods: </strong>A prospective cross-sectional study was conducted on 340 patients diagnosed with glaucoma who were administered ocular hypotensive medication at least for one week before current visit and those who were diagnosed and prescribed the medication, currently presented to the hospital as new attendant. A systematic random sampling technique was used to select study participants. Data was collected using a validated questionnaire by interviewing patients and reviewing their medical charts from May 01 to November 30, 2022. The collected data checked for completeness, entered to SPSS 22. Descriptive and binary logistic regression analysis were done using the software. The findings were presented using tables and Pie-charts. A p-value ≤ 0.05 was used to indicate statistical significance.</p><p><strong>Results: </strong>About 340 patients participated in this study with response rate of 90%. More than half of them (59.4%) were male. Mean age of the study participants was 60.2 ± 3.17SD years. The majority came from rural areas (186 (54.71%). Approximately 62.4% of them were with bilateral glaucoma while 47.10% were at advanced stage at least in one eye. The glaucoma non-adherence rate was 54.71% (95% CI; 50.90-58.50). Forgetfulness (AOR 28.32 (95% CI;14.80-54.16), difficulty with schedule AOR 2.52 (95% CI;1.009-6.29), believing eye drops were not effective AOR 6.35 (95% CI;1.17-34.49) and poor self-efficacy AOR 10.96 (95% CI;1.26-95.57) were barriers significantly associated with non-adherence.</p><p><strong>Conclusion and recommendation: </strong>The nonadherence rate to glaucoma medication among patients with glaucoma attending Hawassa University comprehensive hospital was high (54.71%). Forgetfulness, difficulty with schedule, belief that the drug was not effective and poor self-efficacy were barriers associated with glaucoma medication non-adherence. Health workers better to properly council and inform the patients about the disease nature, goal of treatment, danger of nonadherence to administered medication and mechanism to increase their adherence such as setting reminder.</p>","PeriodicalId":9058,"journal":{"name":"BMC Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11545621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1